Biomarker test for managing early lung nodules after treatment
Part of Cancer clinical trials.
This study looks at lung “biomarkers” (test results from your nodule/tissue) to better predict risk of cancer coming back and to guide long-term follow-up. It may help doctors choose the best surveillance plan after surgery or other treatment for early, potentially curable lung cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older, and you have a lung nodule 8–40 mm that may be early lung cancer (no swollen lymph nodes on scans).
- Doctors have not confirmed the exact lung diagnosis yet, and the nodule isn’t a pure “ground-glass” type or a hilar mass.
- Your planned care would happen at the Moffitt Cancer Center—either surgery there or SBRT radiation there if surgery isn’t recommended.
- You are not currently receiving any cancer treatment, and you don’t have uncontrolled medical problems that would interfere with follow-up.
- You agree to long-term follow-up and are able to understand and sign consent; you can be either fit enough for regular activities or have only mild limits (ECOG 0–1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at lung nodules found on CT scans. Researchers will collect data from your breathing tests and CT scans to better understand how these nodules relate to lung cancer.
This trial follows people with lung nodules over time, using blood and tissue samples to look for metabolic changes that may help understand lung cancer better. If you have a lung nodule found on a CT scan and can safely do lung function tests, this study may be a fit.
This trial uses a simple blood test to look at certain genetic markers that may help doctors decide if a lung nodule is cancerous or not. It is designed for people who have a lung nodule that needs further testing like a biopsy or surgery.
This study is collecting blood samples from people with lung nodules to help design a better test for lung cancer. It may help find cancer earlier without invasive procedures.
This trial tests a new way to find and remove small lung nodules using a robot-guided camera to mark the nodule with dye, then a video-assisted surgery to remove it. It may help patients whose nodules are hard to locate during surgery.
This trial tests an immunotherapy approach to stop high-risk lung spots from turning into cancer. It is for people who are current or former heavy smokers with multiple slow-growing lung nodules that are not yet ready for surgery.
Hear when a new Lung; Node trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.